The CXCR4/CXCL12 receptor/ligand pair has been shown to have a critical role in the progression of many kinds of cancers, including lung cancer,26 colon cancer,27 ovarian cancer,28 melanoma,29 leukemia 30 and breast cancer. This evidence concerns the gene CXCR4 and breast carcinoma.